Avicularin induces apoptosis in NSCLC by promoting USP7-mediated degradation of FOXM1

Jiangyue Du1, Kuai Yu2, Jian Zeng3

  • 1Department of General Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Zhejiang, China.

Insights

Avicularin (Avi) effectively targets non-small cell lung cancer (NSCLC) by degrading the FOXM1 protein, offering a potential new treatment. This natural compound shows promise as a standalone therapy or in combination with existing treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Non-small cell lung cancer (NSCLC) is a major global health concern, necessitating innovative therapeutic approaches.
  • Avicularin (Avi), a flavonoid, demonstrates anti-cancer properties by reducing NSCLC cell viability and inducing apoptosis with low toxicity to normal cells.

Purpose of the Study:

  • To elucidate the mechanism of Avicularin's anti-NSCLC effects.
  • To evaluate Avicularin's therapeutic potential as a monotherapy and in combination with gefitinib.

Main Methods:

  • Investigated Avicularin's impact on FOXM1 protein and mRNA levels in NSCLC cells.
  • Assessed the role of ubiquitination and USP7 in Avicularin's mechanism of action.
  • Evaluated Avicularin's efficacy and toxicity in vivo using A549 xenograft models.
  • Examined the combined effects of Avicularin and gefitinib in NSCLC treatment.

Main Results:

  • Avicularin selectively reduced FOXM1 protein expression via post-transcriptional regulation, promoting its polyubiquitination and degradation by USP7.
  • Overexpression of FOXM1 or USP7 counteracted Avicularin's cytotoxic effects.
  • Avicularin inhibited tumor growth in vivo without systemic toxicity and enhanced gefitinib's anti-cancer activity.

Conclusions:

  • Avicularin exhibits potent anti-NSCLC activity by promoting USP7-dependent degradation of FOXM1.
  • Avicularin holds potential as a novel monotherapy or adjuvant treatment for NSCLC, particularly in combination with EGFR-targeted therapies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.9K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K